Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2ObT0QO
via IFTTT